Reimagining Medication Adherence: A Novel Holistic Model for Hypertension Therapy

Christian Schäfer

DOI: https://doi.org/10.2147/ppa.s442645

2024-02-13

Patient Preference and Adherence

Abstract:Christian Schäfer Department of Business Administration and Health-Care, Baden-Württemberg Cooperative State University Mannheim (DHBW), Mannheim, Germany Correspondence: Christian Schäfer, Department of Business Administration and Health-Care, Baden-Württemberg Cooperative State University Mannheim (DHBW), Coblitzallee 1-9, Mannheim, 68163, Germany, Tel +49 621 4105 1326, Email Purpose: Patients' adherence to the prescribed therapy is influenced by several personal and social factors. However, existing studies have mostly focused on individual aspects. We took a holistic approach to develop a higher-level impact factor model. Patients and Methods: In this independent, non-interventional, cross-sectional and anonymous study design the pharmacist recruited patients who entered the pharmacy and handed in a prescription for a blood pressure medication. The patients received a paper questionnaire with a stamped return envelope to volunteer participation. A total of 476 patients in Germany who reported having at least high normal blood pressure according to the Global Hypertension Practice Guidelines were surveyed. In this study, each patient received an average of 2.49 antihypertensive prescriptions and 7.9% of all patients received a fixed-dose combination. Partial least squares structural equation modeling was performed for model analytics since it enables robust analysis of complex relationships. Results: Emotional attitude, behavioral control, and therapy satisfaction directly explained 65% of therapy adherence. The predictive power of the out-of-sample model for the Q 2 -statistic was significant. The patient's overall therapy satisfaction determined medication adherence. The medication scheme's complexity also influenced the adherence levels. Therapy satisfaction was significantly shaped by the complexity of the medication scheme, behavioral control, and emotional attitude. The results demonstrated the superior performance of fixed-dose combinations against combinations of mono-agents according to the adherence level. Additionally, patient-physician and patient-pharmacist relationships influenced behavioral control of medication therapy execution. According to the A14-scale to measure the level of adherence, 49.6% of patients were classified as adherent and the remainder as non-adherent. Conclusion: The results enable healthcare stakeholders to target attractive variables for intervention to achieve maximum effectiveness. Moreover, the proven predictive power of the model framework enables clinicians to make predictions about the adherence levels of their hypertensive patients. Keywords: compliance, hypertension, theory of planned behavior, PLS-SEM, mediation Medication adherence is defined as "the degree to which a person's behavior corresponds with the agreed recommendations from a healthcare provider". 1 According to the World Health Organization, about 50% of patients with chronic diseases take their long-term medications regularly. 2,3 In the United States, approximately 3–10% of annual healthcare costs ($100–300 billion) are attributable to medication non-adherence. 4 With 40–45% of people in the Western world having at least one chronic disease, lack of adherence to treatment is not only costly to healthcare systems but also deeply embedded in society. 5,6 These data stress the high unmet need for interventions to improve therapeutic adherence. According to the literature, therapy adherence is a complex system with many interrelated and influencing factors. 7 The following major factors impact adherence behavior: 8–12 social peer groups, self-competence to execute the therapy, attitudes and emotions when coping with therapy, sociodemographic and economic factors, disease-related aspects, complexity of the therapy scheme, satisfaction with the therapy, and assistance from important stakeholders such as physicians or pharmacists. Previous studies have mostly focused on analyzing individual aspects of adherence behavior to understand them. It is important to plan detailed interventions and understand the micro-setting as much as possible; however, this approach risks overseeing the overall positive or negative impacts of an intervention on other major variables in a patient's global adherence decision-making process. This lack of understanding of the broader relationships 7,10,13,14 was addressed in our interdisciplinary study. From a therapeutic area perspective, recently published broad multi-factor studies on medication adherence in various conditions include the context of stroke, 15 type 2 diabetes mellitus, 16,17 breast cancer, 18 tuberculosis 19 and medication, but not in the contex -Abstract Truncated-

medicine, general & internal